Role of a Mixture of Polyphenol Compounds Released after Blueberry Fermentation in Chemoprevention of Mammary Carcinoma: In Vivo Involvement of miR-145

• Published in: International journal of molecular sciences Vol. 24; no. 4; p. 3677
• Main Authors: Mallet, Jean-François, Shahbazi, Roghayeh, Alsadi, Nawal, Saleem, Ammar, Sobiesiak, Agnes, Arnason, John Thor, Matar, Chantal
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01-02-2023; MDPI
• Subjects: Acids; Animals; Bioactive compounds; Blueberries; Blueberry Plants - chemistry; Breast cancer; Breast Neoplasms - drug therapy; Breast Neoplasms - genetics; Breast Neoplasms - metabolism; Cancer; cancer stem cells; Carcinogenesis; Carcinogens; Carcinoma; Care and treatment; Catechin; Catechol; Cell culture; Cell growth; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Deregulation; Development and progression; Discriminant analysis; Epigenetic inheritance; Epigenetics; Female; Fermentation; Flavonoids; FOXO1; FOXO1 protein; Gallic acid; Gallic Acid - pharmacology; Gene Expression Regulation, Neoplastic; Humans; Lungs; Mammary gland; Mammary Neoplasms, Animal - drug therapy; Mammary Neoplasms, Animal - genetics; Mammary Neoplasms, Animal - metabolism; Mass spectrometry; Metabolites; Metastases; Metastasis; Mice; MicroRNA; MicroRNAs; MicroRNAs - drug effects; MicroRNAs - metabolism; miRNA; Mixtures; N-ras; Phenolic compounds; Phenols; Phytochemicals; Polyphenols; Polyphenols - pharmacology; Prevention; Protocatechuic acid; Scientific imaging; Signal transduction; Stem cells; Thioguanine; Tumors; Type 2 diabetes; Canada; Ontario; microRNAs; polyphenols; cancer stem cells; N-ras; metastasis; FOXO1
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms24043677

Epigenetic mechanisms such as microRNA (miRNA) deregulation seem to exert a central role in breast cancer initiation and progression. Therefore, targeting epigenetics deregulation may be an effective strategy for preventing and halting carcinogenesis. Studies have revealed the significant role of naturally occurring polyphenolic compounds derived from fermented blueberry fruits in cancer chemoprevention by modulation of cancer stem cell development through the epigenetic mechanism and regulation of cellular signaling pathways. In this study, we first investigated the phytochemical changes during the blueberry fermentation process. Fermentation favored the release of oligomers and bioactive compounds such as protocatechuic acid (PCA), gallic acid, and catechol. Next, we investigated the chemopreventive potentials of a polyphenolic mixture containing PCA, gallic acid, and catechin found in fermented blueberry juice in a breast cancer model by measuring miRNA expression and the signaling pathways involved in breast cancer stemness and invasion. To this end, 4T1 and MDA-MB-231 cell lines were treated with different doses of the polyphenolic mixture for 24 h. Additionally, female Balb/c mice were fed with this mixture for five weeks; two weeks before and three weeks after receiving 4T1 cells. Mammosphere formation was assayed in both cell lines and the single-cell suspension obtained from the tumor. Lung metastases were counted by isolating 6-thioguanine-resistant cells present in the lungs. In addition, we conducted RT-qPCR and Western blot analysis to validate the expression of targeted miRNAs and proteins, respectively. We found a significant reduction in mammosphere formation in both cell lines treated with the mixture and in tumoral primary cells isolated from mice treated with the polyphenolic compound. The number of colony-forming units of 4T1 cells in the lungs was significantly lower in the treatment group compared to the control group. miR-145 expression significantly increased in the tumor samples of mice treated with the polyphenolic mixture compared to the control group. Furthermore, a significant increase in FOXO1 levels was noted in both cell lines treated with the mixture. Overall, our results show that phenolic compounds found in fermented blueberry delay the formation of tumor-initiating cells in vitro and in vivo and reduce the spread of metastatic cells. The protective mechanisms seem to be related, at least partly, to the epigenetic modulation of mir-145 and its signaling pathways.